[{"Assets_0_Q3_USD":"48187000000.0","CIK":"59478","CommonStockDividendsPerShareDeclared_3_Q3_USD":"1.7","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"1.22","EarningsPerShareBasic_3_Q3_USD":"4.25","EarningsPerShareDiluted_1_Q3_USD":"1.22","EarningsPerShareDiluted_3_Q3_USD":"4.23","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q3_USD":"197100000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"5104200000.0","NetIncomeLoss_1_Q3_USD":"1110100000.0","NetIncomeLoss_3_Q3_USD":"3855600000.0","OfficialName":"Eli Lilly and Company Common Stock","PaymentsOfDividends_3_Q3_USD":"2313500000.0","RevenuesConverted_1_Q3_USD":"6772800000.0","RevenuesConverted_3_Q3_USD":"20318500000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"7954100000.0","StockholdersEquity_0_Q3_USD":"7757000000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"910800000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"911700000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"906700000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"907700000.0","filed":"20211027","footnote":null,"form":"10-Q","fp":"Q3","fy":"2021.0","name":"ELI LILLY & CO","period":"20210930","qtrs":"0","uom":"USD"}]